Tenaya Therapeutics, Inc. (TNYA)

Tenaya Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62.67	4.32	45.68	95.27	38.13	128.54
Short-Term Investments	9	57.12	58.96	91.26	213.17	-
Cash & Short-Term Investments	71.67	61.45	104.64	186.53	251.3	128.54
Cash Growth	-27.83%	-41.28%	-43.90%	-25.77%	95.51%	382.76%
Other Receivables	-	-	-	2.25	-	-
Receivables	-	-	-	2.25	-	-
Prepaid Expenses	3.99	5.09	5.78	4.04	4.06	1.43
Other Current Assets	0.22	0.84	1.16	0.94	-	-
Total Current Assets	75.88	67.38	111.58	193.75	255.36	129.96
Property, Plant & Equipment	41.97	47.75	53.26	62.7	54.71	17.19
Long-Term Investments	-	-	-	17.7	-	-
Other Long-Term Assets	4.31	4.82	5.68	4.79	4.13	1.01
Total Assets	122.15	119.94	170.52	278.95	314.19	148.16
Accounts Payable	3.3	5.16	5.63	9.58	10.72	1.02
Accrued Expenses	5.87	7.47	12.03	10	6.03	2.81
Current Portion of Leases	2.83	2.78	4.32	4.01	1.99	-
Current Income Taxes Payable	0.52	0.35	0.28	-	-	-
Other Current Liabilities	0.14	0.21	0.48	0.67	3.03	1.22
Total Current Liabilities	12.65	15.98	22.73	24.25	21.77	5.04
Long-Term Leases	9.38	10.83	8.11	11.09	13.71	-
Other Long-Term Liabilities	0.29	0.28	0.25	0.23	0.18	3.68
Total Liabilities	22.32	27.09	31.09	35.57	35.66	8.72
Common Stock	0.02	0.01	0.01	0.01	0	-
Additional Paid-In Capital	664.37	607.23	542.81	522.95	434.2	1.58
Retained Earnings	-564.56	-514.41	-403.28	-279.2	-155.53	-82.81
Comprehensive Income & Other	-0	0.03	-0.11	-0.38	-0.14	-0.09
Total Common Equity	99.83	92.85	139.42	243.38	278.53	-81.32
Shareholders' Equity	99.83	92.85	139.42	243.38	278.53	139.44
Total Liabilities & Equity	122.15	119.94	170.52	278.95	314.19	148.16
Total Debt	12.21	13.61	12.42	15.1	15.7	-
Net Cash (Debt)	59.46	47.84	92.22	189.13	235.6	128.54
Net Cash Growth	-28.99%	-48.13%	-51.24%	-19.72%	83.30%	382.76%
Net Cash Per Share	0.53	0.56	1.25	4.22	13.29	132.23
Filing Date Shares Outstanding	162.98	87.58	78.52	66.87	41.29	1.21
Total Common Shares Outstanding	162.98	86.54	68.33	66.86	41.29	1.21
Working Capital	63.22	51.4	88.85	169.51	233.58	124.92
Book Value Per Share	0.61	1.07	2.04	3.64	6.75	-67.18
Tangible Book Value	99.83	92.85	139.42	243.38	278.53	-81.32
Tangible Book Value Per Share	0.61	1.07	2.04	3.64	6.75	-67.18
Machinery	42.1	40.07	40.28	39.98	12.64	8.97
Construction In Progress	-	1.92	1.73	3.13	32.56	7.68
Leasehold Improvements	26.22	26.16	25.61	23.61	7.24	7.24

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q